FI971013A - Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi - Google Patents

Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi Download PDF

Info

Publication number
FI971013A
FI971013A FI971013A FI971013A FI971013A FI 971013 A FI971013 A FI 971013A FI 971013 A FI971013 A FI 971013A FI 971013 A FI971013 A FI 971013A FI 971013 A FI971013 A FI 971013A
Authority
FI
Finland
Prior art keywords
pallidipine
preparation
platelet aggregation
induced platelet
collagen induced
Prior art date
Application number
FI971013A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971013A0 (fi
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI971013A publication Critical patent/FI971013A/fi
Publication of FI971013A0 publication Critical patent/FI971013A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI971013A 1994-09-12 1997-03-11 Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi FI971013A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
FI971013A true FI971013A (fi) 1997-03-11
FI971013A0 FI971013A0 (fi) 1997-03-11

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971013A FI971013A0 (fi) 1994-09-12 1997-03-11 Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi

Country Status (22)

Country Link
US (1) US5882887A (sl)
EP (1) EP0781334A1 (sl)
JP (1) JPH10505502A (sl)
CN (1) CN1075836C (sl)
AU (1) AU701643B2 (sl)
BG (1) BG63276B1 (sl)
BR (1) BR9508910A (sl)
CA (1) CA2199719A1 (sl)
CZ (1) CZ76297A3 (sl)
FI (1) FI971013A0 (sl)
HU (1) HU222398B1 (sl)
IL (1) IL115272A0 (sl)
MX (1) MX9701720A (sl)
NO (1) NO971110L (sl)
NZ (1) NZ293261A (sl)
PL (1) PL184617B1 (sl)
RO (1) RO117971B1 (sl)
RU (1) RU2186110C2 (sl)
SI (1) SI9520093A (sl)
SK (1) SK29297A3 (sl)
WO (1) WO1996008563A1 (sl)
ZA (1) ZA957649B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774107B1 (en) * 1999-03-18 2004-08-10 Merck Patent Gmbh Protein for blocking platelet adhesion
CA2578072A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (en) * 2011-06-14 2012-12-20 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
KR102063195B1 (ko) 2012-02-07 2020-01-07 글로벌 바이오 테라퓨틱스, 인크. 핵산 전달의 구획화된 방법 및 이의 조성물 및 용도
MX2015002994A (es) 2012-09-07 2016-01-14 Inserm Inst Nat De La Santé Et De La Rech Médicale Peptidos de inhibidores obtenidos del receptor desencadenante expresado en celulas mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
CN118139655A (zh) 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371041A1 (en) * 1987-06-24 1990-06-06 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
AU672584B2 (en) * 1991-09-05 1996-10-10 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
HU222398B1 (hu) 2003-06-28
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
CA2199719A1 (en) 1996-03-21
BR9508910A (pt) 1997-10-28
MX9701720A (es) 1997-06-28
PL319078A1 (en) 1997-07-21
US5882887A (en) 1999-03-16
CN1075836C (zh) 2001-12-05
AU3565795A (en) 1996-03-29
BG63276B1 (bg) 2001-08-31
SI9520093A (en) 1997-08-31
PL184617B1 (pl) 2002-11-29
NO971110L (no) 1997-05-07
JPH10505502A (ja) 1998-06-02
CZ76297A3 (cs) 1998-01-14
NO971110D0 (no) 1997-03-11
WO1996008563A1 (en) 1996-03-21
IL115272A0 (en) 1995-12-31
ZA957649B (en) 1996-04-15
FI971013A0 (fi) 1997-03-11
CN1159828A (zh) 1997-09-17
SK29297A3 (en) 1997-10-08
BG101226A (en) 1998-10-30
EP0781334A1 (en) 1997-07-02
RU2186110C2 (ru) 2002-07-27
RO117971B1 (ro) 2002-11-29
NZ293261A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
EE03616B1 (et) Uued vereliistakute agregatsiooni pärssivad ained
FI973426A0 (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
NO964383L (no) Matvareforpakning
DE69408528D1 (de) Schneidautomat zum dreidimensionalen schneiden von nahrungsmitteln
FI971013A (fi) Menetelmä kollageenin indusoiman verihiutaleaggregaation modifioidun inhibiittorin, pallidipiinin tuottamiseksi
NO970056D0 (no) Trekantet artikkelemballasje
AU2936795A (en) Novel compounds with platelet aggregation inhibitor activity
NO963276D0 (no) Emballasje for næringsmidler
NO173683C (no) Fremgangsmaate for fremstilling av et proteinholdig naeringsmiddelprodukt
BR9509347A (pt) Materiais de multicamada adequados para a produção de embalagens
AU7526398A (en) Novel carboxamides as platelet aggregation inhibitors
EE9800109A (et) 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
FI972065A (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
FI942102A0 (fi) Menetelmä alumiinioksaanien valmistamiseksi
FI961627A (fi) Selluloosakuori lihatuotteita varten
DE69819075D1 (de) Verfahren zum konditionierten Verpacken von Schalentieren
FI951064A (fi) Menetelmä kaksikammioisen painepakkauksen valmistamiseksi
NO891701D0 (no) Fremgangsmaate for fremstilling av et dehydratisert kjoettprodukt.
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
AU3734093A (en) Protein for inhibiting collagen-stimulated platelet aggregation
KR950703960A (ko) 혈소판 응집 억제제(platelet aggregation inhibitor)
FI944460A0 (fi) Menetelmä lääkepreparaatin valmistamiseksi
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
FI940551A0 (fi) Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
DK0817751T3 (da) Fødevareemballage